Clinical Demographics by Indication for Examination for 401,548 Diagnostic Mammography Examinations from 2007 - 2013
Based on BCSC data through 2013
Work-Up of Abnormal Screening Exams | Short-Interval Follow-Up | Evaluation of Breast Problem/ No Lump or Lump Unknown | Evaluation of Breast Problem/ Palpable Lump | All Diagnostic Exams** | |
---|---|---|---|---|---|
All examinations |
128,976 |
51,440 |
74,426 |
35,308 |
401,548 |
Age (y) |
|
|
|
|
|
18-39 |
5,266 (4.1) |
2,412 (4.7) |
10,242 (13.8) |
9,508 (26.9) |
36,768 (9.2) |
40-44 |
19,804 (15.4) |
6,747 (13.1) |
9,142 (12.3) |
5,770 (16.3) |
57,762 (14.4) |
45-49 |
20,787 (16.1) |
7,756 (15.1) |
10,073 (13.5) |
5,698 (16.1) |
62,621 (15.6) |
50-54 |
19,568 (15.2) |
7,855 (15.3) |
9,950 (13.4) |
4,190 (11.9) |
58,870 (14.7) |
55-59 |
16,900 (13.1) |
6,967 (13.5) |
8,904 (12.0) |
2,973 (8.4) |
49,748 (12.4) |
60-64 |
15,214 (11.8) |
6,398 (12.4) |
8,061 (10.8) |
2,339 (6.6) |
43,333 (10.8) |
65-69 |
12,234 (9.5) |
5,064 (9.8) |
6,443 (8.7) |
1,750 (5.0) |
34,787 (8.7) |
70-74 |
8,179 (6.3) |
3,527 (6.9) |
4,580 (6.2) |
1,099 (3.1) |
24,009 (6.0) |
75-79 |
5,768 (4.5) |
2,470 (4.8) |
3,228 (4.3) |
822 (2.3) |
16,984 (4.2) |
80+ |
5,256 (4.1) |
2,244 (4.4) |
3,803 (5.1) |
1,159 (3.3) |
16,666 (4.2) |
Mean (y) |
55.9 |
56.5 |
54.6 |
48.8 |
54.8 |
Median (y) |
54 |
55 |
53 |
46 |
53 |
Family history of breast cancer | |||||
Yes |
21,824 (16.9) |
9,418 (18.3) |
14,478 (19.5) |
5,508 (15.6) |
55,182 (13.7) |
No or unknown |
107,152 (83.1) |
42,022 (81.7) |
59,948 (80.5) |
29,800 (84.4) |
346,366 (86.3) |
Personal history of breast cancer | |||||
Yes |
14,797 (11.5) |
10,820 (21.0) |
18,142 (24.4) |
2,078 (5.9) |
63,450 (15.8) |
No or unknown |
114,179 (88.5) |
40,620 (79.0) |
56,284 (75.6) |
33,230 (94.1) |
338,098 (84.2) |
Previous mammography performed | |||||
Yes |
126,464 (98.1) |
50,825 (98.8) |
62,691 (84.2) |
25,324 (71.7) |
369,362 (92.0) |
No or unknown |
2,512 (1.9) |
615 (1.2) |
11,735 (15.8) |
9,984 (28.3) |
32,186 (8.0) |
Note: Numbers in parentheses are percentages.
** Includes 94,228 exams from one registry for which sub-classification of diagnostic indication(e.g., additional evaluation, short interval follow-up, etc.) was not available.
Table numbers last updated Mar 26, 2017.
The following must be cited when reproducing this data:
"The Breast Cancer Surveillance Consortium and its data collection and sharing activities are funded by the National Cancer Institute (P01CA154292). Downloaded xx/xx/xxxx from the Breast Cancer Surveillance Consortium Web site - http://www.bcsc-research.org/."